Elkhorn Partners’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-192
| Closed | -$258K | – | 36 |
|
|
2017
Q3 | $258K | Sell |
192
-140
| -42% | -$188K | 0.17% | 28 |
|
|
2017
Q2 | $268K | Sell |
332
-292
| -47% | -$236K | 0.17% | 31 |
|
|
2017
Q1 | $385K | Sell |
624
-76
| -11% | -$46.9K | 0.22% | 26 |
|
|
2016
Q4 | $375K | Sell |
700
-44
| -6% | -$23.6K | 0.23% | 28 |
|
|
2016
Q3 | $385K | Sell |
744
-56
| -7% | -$29K | 0.23% | 28 |
|
|
2016
Q2 | $328K | Buy |
800
+76
| +10% | +$31.2K | 0.21% | 31 |
|
|
2016
Q1 | $385K | Sell |
724
-4
| -0.5% | -$2.13K | 0.24% | 26 |
|
|
2015
Q4 | $555K | Sell |
728
-152
| -17% | -$116K | 0.33% | 25 |
|
|
2015
Q3 | $482K | Hold |
880
| – | – | 0.3% | 28 |
|
|
2015
Q2 | $517K | Hold |
880
| – | – | 0.31% | 24 |
|
|
2015
Q1 | $690K | Hold |
880
| – | – | 0.39% | 23 |
|
|
2014
Q4 | $601K | Buy |
+880
| New | +$601K | 0.35% | 25 |
|